−725 KRW
−12.77 B KRW
4.35 B KRW
16.07 M
About NGENEBIO CO., LTD.
Sector
Industry
CEO
Dae-Chul Choi
Website
Headquarters
Seoul
Founded
2015
ISIN
KR7354200008
FIGI
BBG00Y1QKB54
NGeneBio Co., Ltd. engages in the research and development of diagnostic products related to cancer. Its products include next generation sequencing based testing kit for in vitro diagnosis (IVD), anti-cancer companion diagnostics, prenatal diagnosis kit (IVD) for rare diseases and analysis software. The company was founded on October 30, 2015 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 354200 is 2,130 KRW — it has decreased by −5.33% in the past 24 hours. Watch NGENEBIO CO., LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange NGENEBIO CO., LTD. stocks are traded under the ticker 354200.
354200 stock has fallen by −1.39% compared to the previous week, the month change is a −17.12% fall, over the last year NGENEBIO CO., LTD. has showed a −58.67% decrease.
354200 reached its all-time high on Dec 15, 2020 with the price of 38,605 KRW, and its all-time low was 1,980 KRW and was reached on Dec 9, 2024. View more price dynamics on 354200 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
354200 stock is 6.34% volatile and has beta coefficient of −0.07. Track NGENEBIO CO., LTD. stock price on the chart and check out the list of the most volatile stocks — is NGENEBIO CO., LTD. there?
Today NGENEBIO CO., LTD. has the market capitalization of 42.04 B, it has increased by 3.15% over the last week.
Yes, you can track NGENEBIO CO., LTD. financials in yearly and quarterly reports right on TradingView.
354200 net income for the last quarter is −4.15 B KRW, while the quarter before that showed −2.38 B KRW of net income which accounts for −74.00% change. Track more NGENEBIO CO., LTD. financial stats to get the full picture.
No, 354200 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 110.00 employees. See our rating of the largest employees — is NGENEBIO CO., LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. NGENEBIO CO., LTD. EBITDA is −12.26 B KRW, and current EBITDA margin is −277.67%. See more stats in NGENEBIO CO., LTD. financial statements.
Like other stocks, 354200 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NGENEBIO CO., LTD. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So NGENEBIO CO., LTD. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating NGENEBIO CO., LTD. stock shows the sell signal. See more of NGENEBIO CO., LTD. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.